Boehringer Ingelheim and Vitae Pharmaceuticals, Inc., announced today that they have entered into a significant worldwide collaboration to research and develop beta-secretase (BACE) inhibitors for th
read more » Discuss Add this link to...Bury Add to:
| Bookmarks